Description of the cohort
A random sample of 51 patients who had already finished treatment in our unir were approached for participation in this study. Acceptance was 98% with just one family refusing to participate. The 50 initial patients (ages ranging from 2 months to 22 years) were recruited from October 2019 to April 2022.
A detailed clinical description of the cohort is summarised in Table 2. The malignancies or hematologic problems are detailed in Table 3.